Open Access 01-02-2021 | Polyneuropathy | Correction
Correction to: A Global Survey of Disease Burden in Patients Who Carry a Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy
Published in: Advances in Therapy | Issue 2/2021
Login to get accessExcerpt
The original article is published with few errors in Table 3, Fig. 2 and Fig. 3. The correct Table 3, Fig. 2 and Fig. 3 are given below.
Global, likely CIDP (n = 222)
|
Global, somewhat likely CIDP (n = 204)
|
Global, unlikely CIDP (n = 169)
|
|||
---|---|---|---|---|---|
Sex, male, %
|
46
|
39
|
51
|
||
Age (at diagnosis), n (%)
|
|||||
≤ 29
|
15 (6.76)
|
16 (7.84)
|
9 (5.33)
|
||
30–39
|
32 (14.41)
|
35 (17.16)
|
19 (11.24)
|
||
40–49
|
46 (20.72)
|
50 (24.51)
|
30 (17.75)
|
||
50–59
|
69 (31.01)
|
63 (30.88)
|
49 (28.99)
|
||
60–69
|
47 (21.17)
|
29 (14.22)
|
41 (24.26)
|
||
70–79
|
12 (5.41)*
|
10 (4.9)
|
20 (11.83)*
|
||
≥ 80
|
1 (0.45)
|
1 (0.49)
|
1 (0.59)
|
||
Employment status (at diagnosis), %
|
|||||
Employed
|
71
|
68
|
59
|
||
Paid full-time
|
61
|
63
|
51
|
||
Paid part-time
|
10
|
5
|
8
|
||
Retired
|
11
|
7
|
20
|
||
Student
|
2
|
3
|
2
|
||
On disability
|
6
|
10
|
8
|
||
Unemployed
|
5
|
4
|
5
|
||
Other/unpaid work
|
5
|
7
|
6
|
||
Current treatment at survey completion, %
|
|||||
IVIg
|
61
|
61
|
59
|
||
SCIg
|
2
|
3
|
2
|
||
Corticosteroids
|
23
|
22
|
15
|
||
IVIg and steroids
|
12
|
14
|
9
|
||
Other immunosuppressive drugs
|
15
|
17
|
18
|
||
Plasma exchange
|
3
|
2
|
2
|